ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,036
Screening encounters
2,197
Diagnostic referrals
424
Outstanding pathways
190

Screening pathway

  1. Screening2,197Encounters
  2. Positive finding739Documented findings
  3. Referral424Diagnostic referrals
  4. Follow-up458Diagnostic visits
  5. Outcome234Resolved pathways

Stage totals use different units. Pending pathways: 190. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4792 · EXP-4792Synthetic · Site B

Full participant history through 2025-12-27, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-04-06
  4. · Diagnostic referral · EXP-4792-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-12-05
  11. · Follow-up disposition · Resolved · EXP-4792-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2036 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1626 · Expanded synthetic participant 1626Site A — Urban Referral Hub
EXP-1628 · Expanded synthetic participant 1628Site A — Urban Referral Hub
EXP-1631 · Expanded synthetic participant 1631Site A — Urban Referral Hub
EXP-1643 · Expanded synthetic participant 1643Site D — Community Engagement Programme
EXP-1645 · Expanded synthetic participant 1645Site B — Peri-Urban Access Programme
EXP-1649 · Expanded synthetic participant 1649Site E — Resource-Constrained Navigation Programme
EXP-1650 · Expanded synthetic participant 1650Site A — Urban Referral Hub
EXP-1653 · Expanded synthetic participant 1653Site B — Peri-Urban Access Programme
EXP-1655 · Expanded synthetic participant 1655Site A — Urban Referral Hub
EXP-1658 · Expanded synthetic participant 1658Site D — Community Engagement Programme
EXP-1669 · Expanded synthetic participant 1669Site A — Urban Referral Hub
EXP-1673 · Expanded synthetic participant 1673Site B — Peri-Urban Access Programme
EXP-1674 · Expanded synthetic participant 1674Site C — Rural Outreach Programme
EXP-1675 · Expanded synthetic participant 1675Site B — Peri-Urban Access Programme
EXP-1678 · Expanded synthetic participant 1678Site D — Community Engagement Programme
EXP-1681 · Expanded synthetic participant 1681Site D — Community Engagement Programme
EXP-1682 · Expanded synthetic participant 1682Site D — Community Engagement Programme
EXP-1684 · Expanded synthetic participant 1684Site E — Resource-Constrained Navigation Programme
EXP-1686 · Expanded synthetic participant 1686Site C — Rural Outreach Programme
EXP-1690 · Expanded synthetic participant 1690Site B — Peri-Urban Access Programme
EXP-1691 · Expanded synthetic participant 1691Site C — Rural Outreach Programme
EXP-1695 · Expanded synthetic participant 1695Site B — Peri-Urban Access Programme
EXP-1696 · Expanded synthetic participant 1696Site D — Community Engagement Programme
EXP-1697 · Expanded synthetic participant 1697Site C — Rural Outreach Programme
EXP-1703 · Expanded synthetic participant 1703Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
933
HPV DNA
943
Cytology
321

Navigation activity

Barrier documented
347
Contact attempt
620
Navigation intervention
142
Diagnostic booking
515
Diagnostic visit
458

Documented barriers

Contact difficulty
102
Transport difficulty
119
Appointment coordination
126

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.